|  
---|---  
|  By: Parker | H.B. No. 3707  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to value-based arrangements for prescription drugs in  
| Medicaid.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 531, Government Code, is amended by  
| adding Section 531.0701 to read as follows:  
|  
| _Sec._ ___531.0701._ _____VALUE-BASED ARRANGEMENTS. Subject to_  
| _531.071, the commission may enter into a written agreement with a_  
| _manufacturer of prescription drugs as defined by 42 U.S.C. Section_  
| _1396r-8(k)(5) and its subsequent amendments, including a_  
| _subsidiary or affiliate of a manufacturer, based on outcomes data,_  
| _or other metrics agreed to in writing by the state and a_  
| _pharmaceutical manufacturer. Such agreements may include but not_  
| _be limited to rebates, discounts, price reductions, contributions,_  
| _risk sharing, reimbursements, deferral of payments (e.g._  
| _installment payments), guarantees, patient care, shared savings_  
| _payments, withholds, or bonuses or anything of value._  
|  SECTION 2. The Health and Human Services Commission shall  
| amend contracts with managed care plans to ensure those contracts  
| comply with Section 531.0701, Government Code, as added by this  
| Act.  
|  SECTION 3. This Act takes effect September 1, 2019.

